Mesenchymal traits at the convergence of tumor-intrinsic and -extrinsic mechanisms of resistance to immune checkpoint blockers

Targeting of immune checkpoint blockers (ICBs), such as cytotoxic T-lymphocyte antigen-4 and programmed-death 1/programmed-death ligand 1, has dramatically changed the landscape of cancer treatment. Seeing patients who were refractory to conventional therapy recover after immunotherapy, with high ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Trono, Paola, Sistigu, Antonella, Palermo, Belinda, Ciliberto, Gennaro, Nisticò, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2017
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289012/
https://www.ncbi.nlm.nih.gov/pubmed/33525801
http://dx.doi.org/10.1042/ETLS20170068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289012/
https://www.ncbi.nlm.nih.gov/pubmed/33525801
http://dx.doi.org/10.1042/ETLS20170068

Ejemplares similares